Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms

Antibiotic Resistant Community-Acquired E. Coli

NCT00298103 ·Status: COMPLETED

Determination of Genetic Relatedness of Linezolid-resistant Vancomycin-resistant Enterococci (VRE) Surveillance Cultures

NCT00475891 ·Status: COMPLETED

Prospective Study of Drug Resistant Pathogens Among Liver, Intestinal and Multivisceral Transplant Recipients

NCT00235664 ·Status: COMPLETED

Infections Caused by ESbL-Producing Enterobacteriaceae in Italy

NCT00404625 ·Status: UNKNOWN

Impact of Beta-lactams on the Microbiota and Relative Fecal Abundance of Mulltidrug Resistant Bacteria

NCT03338738 ·Status: COMPLETED ·Phase: NA

A Post-Intervention Surveillance Study Regarding the Acquisition Rate of ESBL-KP, Ecoli

NCT00724919 ·Status: COMPLETED

Risk Factors for Carbapenem-resistant Acinetobacter Baumannii

NCT00462579 ·Status: COMPLETED

Extended Spectrum Betalactamase Producing Bacteria; Epidemiology and Treatment in Non-hospitalized Patients

NCT01838213 ·Status: COMPLETED

Emergence of Resistance in Intestinal Microflora During Carbapenem Treatments

NCT01703299 ·Status: COMPLETED

The Prevalence of Extend-Spectrum β-Lactamase (ESBL) Producing Isolates Among Common Enterobacteriaceae in Taiwan

NCT01725841 ·Status: COMPLETED

Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia Coli

NCT04764500 ·Status: ACTIVE_NOT_RECRUITING

Emergence of Gram-negative Resistance in Blood Culture Isolates of Solid-organ Transplant Recipients

NCT00304330 ·Status: COMPLETED

Can the Relative Fecal Abundance of BLSE and the Digestive Microbiota be Predictive of the Risk of Infection in a Carrier Patient?

NCT04699981 ·Status: UNKNOWN ·Phase: NA

Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacteria

NCT06910878 ·Status: RECRUITING

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study

NCT01764490 ·Status: COMPLETED

Clinical and Microbiologic Characteristics of Cephalosporin-Resistant E. Coli-PITT Protocol

NCT00877708 ·Status: COMPLETED

GSK2251052 in the Treatment of Complicated Intra-abdominal Infections

NCT01381562 ·Status: TERMINATED ·Phase: PHASE2

Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037)

NCT00389987 ·Status: COMPLETED ·Phase: PHASE3

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study.

NCT02852902 ·Status: COMPLETED

Treatment of Extended Spectrum Betalactamase Producing Bacteria Causing Urinary Tract Infections in General Practice

NCT01531023 ·Status: COMPLETED

Treatment of Bacterial Vaginosis

NCT00324818 ·Status: COMPLETED ·Phase: PHASE4

Prevalence of Enterobacteria With Decreased Susceptibility to Carbapenems in Eastern Inter- Region

NCT02803710 ·Status: UNKNOWN

Understanding and Modeling Reservoirs, Vehicles and Transmission of ESBL-producing Enterobacteriaceae in the Community and Long Term Care Facilities

NCT03477084 ·Status: COMPLETED

Risk Factors for Pyogenic Liver Abscess With Carbapenem-resistant Klebsiella Pneumoniae: A Matched Case-control Study

NCT05521139 ·Status: COMPLETED

Postoperative Anti-infective Strategy Following Pancreaticoduodenectomy in Patients With Preoperative Biliary Stent

NCT06123169 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3